Pioneering
Epigenetics Through Collaborative Science
We offer DNA methylation services to academic researchers, healthcare providers, clinical institutions, and industry leaders.
Our Services
Epigenetic Predictors
- 50+ Biological Age Clocks
- 12 Organ-Specific System Ages
- 10 Marioni Predictors (GrimAge)
- 6 Methylation Risk Scores
- 5 Physical Fitness Predictors
Biomarker Analysis
- 1,600+ Biomarkers (EPIC array)
- 100+ Biomarkers (MSA array)
- Metabolites, Proteins, Clinical Outputs
- 12-Cell Immune Deconvolution
- Derived Immune Ratios
Statistical Analysis
- Genome-wide EWAS
- DMR Analysis (DMRcate/bumphunter)
- Pathway Enrichment (GO/KEGG)
- Longitudinal & Cross-sectional
- Interaction Models (DiD)
Benefits of Partnership
High-Throughput, CLIA-Certified Precision
Biological age, the age of 11 key organ systems like the brain, heart, and liver, and the speed of aging. TruAge measures 75+ key longevity biomarkers and reflects the net sum of all environmental and lifestyle factors.
Fast Turnaround Time
Optimized workflows deliver results in 2–4 weeks from sample receipt — helping you move from collection to insights without delay.
Sample & Array Flexibility
We process diverse tissue types — including blood, saliva, and solid tissue — and design custom or standard arrays to meet your study's needs.
Free Bioinformatics Support
Gain access to our expert bioinformatics team for advanced analysis, visualization, and publication-ready outputs, plus support for co-authorship opportunities.
Custom Solutions & Scalability
From pilot projects to population-scale studies, our custom array design, data analysis, and scalable infrastructure support every stage of your research.
Access to Exclusive Algorithms & Databases
Tap into the world's largest DNA methylation database and over 1,000 proprietary algorithms — including Epigenetic Biomarker Proxies (EBPs)™ unavailable anywhere else.
TruDiagnostic™ is the gold standard for epigenetic research.
We don’t just process samples. We partner with you to generate meaningful, publishable, and predictive insights that accelerate discovery and drive results.
Collaborate With Us
Our Algorithms
Our proprietary tools translate methylation signatures into advanced metrics, including biological age, immune composition, disease risk, and predicted clinical biomarkers. This allows researchers and clinicians to see what is actively unfolding in the body, far beyond what static genetic tests can reveal.
Biological Age Clocks
Multiple validated aging algorithms — including OMICmAge™, SYMPHONYAge™, and DunedinPACE™ — to quantify biological age, pace of aging, and organ-specific aging.
Read More
Epigenetic Biomarker Proxies (EBPs)™
Machine learning models trained to predict traditional clinical biomarkers (e.g., CRP, glucose, NAD+) from methylation signatures — 100+ multi-omic variables from a single sample.
Read More
Deconvolution Algorithms
Immune cell-type deconvolution models infer immune composition directly from methylation data, enabling non-invasive immune profiling and inflammation tracking without additional assays.
Read More
Methylation Risk Scores (MRS)
Next-gen risk stratification. MRS models calculate disease probability based on composite methylation signatures — offering predictive power above and beyond genomics alone.
Read More
Who We Serve
We collaborate with pioneers across clinical, academic, and commercial fields to push the boundaries of what's possible in longevity science and preventive health.
Academic Institutions
Explore cutting-edge epigenetic insights that decode your health beyond traditional genetics, driving personalized healthcare solutions.
Clinical Research Organizations
Understand how your body's age differs from your chronological age, influencing your long-term health and wellness strategies.
Healthcare Providers & Clinics
Discover personalized recommendations tailored to your DNA, optimizing your health through precision medicine.
Academic Institutions
Learn about our partnerships with leading institutions, driving scientific breakthroughs and trusted, validated results.
Our Impact By The Numbers
6 Trilion
DNA Markers Measured To Date
100,000+
Individuals Tested
25+
25+ Peer-reviewed Publications
Our Array Platforms
We offer advanced DNA methylation profiling services to academic researchers, clinical practitioners, and commercial partners using Illumina's cutting-edge technology. Each platform designed to meet specific research needs, from large-scale population studies to in-depth epigenetic investigations.
Biological Age Clocks
Multiple validated aging algorithms — including OMICmAge™, SYMPHONYAge™, and DunedinPACE™ — to quantify biological age, pace of aging, and organ-specific aging.
Learn More
EPIC v2.0 Array
Industry-standard whole-genome methylation array measuring 935,000+ CpG sites — ideal for in-depth epigenetic investigations and discovery research.
Learn More
Custom Arrays
Bespoke array designs tailored to your specific research question — built in collaboration with our methylation experts and bioinformatics team.
Learn More
Interventional Trial Highlights
Our partnerships yield groundbreaking research findings
PUBLICATION · 2026
OMICmAge: the leading biological age clock.
A Harvard and TruDiagnostic collaboration integrated DNA methylation with multi-omics data to build a clock that predicts chronic disease and mortality — validated in over 14,000 TruDiagnostic samples.
Read the research
.png)
PUBLICATION · 2026
DunedinPACE is the strongest individual predictor of all-cause mortality.
In a 7.4-year study of 1,083 older adults, our pace of aging clock outperformed 14 leading longevity biomarkers — including inflammation markers, grip strength, and cognitive tests.
Read the research
PUBLICATION · 2024
Epigenetic biomarkers outperform traditional labs in disease prediction.
Harvard & TruDiagnostic found that epigenetic biomarkers outperform traditional labs by 62%. They offer faster, more comprehensive insights from a single at-home sample.
Read the research
.png)
PARTNERSHIP · 2024
R&D partnership with L'Oréal advances beauty and longevity science through epigenomics.
TruDiagnostic and L'Oréal are partnering to decode how epigenetics governs long-term skin and hair aging — moving beyond surface-level skincare to the biology underneath.
Read the research
.png)
PUBLICATION · 2024
DeepStrataAge reveals stage- and sex-divergent aging dynamics.
Built on 29,167 DNA methylation samples, DeepStrataAge is the first deep-learning clock to reveal how aging diverges by life stage and biological sex.
Read the research
.png)
PUBLICATION · 2024
51 longevity interventions ranked across multiple aging clocks in largest meta-analysis of its kind.
Yale and TruDiagnostic evaluated how therapies, supplements, and lifestyle changes affect epigenetic age.
Read the research
80+ ACADEMIC COLLABORATORS
Collaborators
135+ PUBLICATIONS IN 5 YEARS
Research Articles
With over 135+ scientific articles published, our research team is at the forefront of epigenetic studies. Each publication reflects our commitment to advancing scientific knowledge and providing valuable insights into the mechanisms of aging, disease, and health. Our work continues to push the boundaries of what is known, contributing significantly to the scientific community.
Read All Articles
Interested in partnering with us?
Whether you're an academic researcher, healthcare provider, clinical institution, or industry partner, we'd love to start the conversation. Reach out to our partnerships team and we'll match you with the right people, platforms, and protocols to bring your study to life.
Submit inquiry